A journal switches to a new publisher, then corrects a paper. What should happen to the old version?

In January 2022, The Oncologist switched publishers from Wiley to Oxford University Press. 

Last month, the journal issued an extensive correction for one of its most popular articles, a 2020 paper that describes results of a clinical trial the authors claimed found a homeopathic intervention improved quality of life and survival for people with advanced lung cancer. 

The article page that remains on Wiley’s website, however, does not reflect the recent correction. 

Continue reading A journal switches to a new publisher, then corrects a paper. What should happen to the old version?

After saying it would retract an article, Cureus changed its mind

Karen Rech, a hematopathologist at Mayo Clinic in Rochester, Minn., was reading a case report about a rare disease when she recognized the patient. 

Although the authors of the paper were affiliated with the University of North Dakota School of Medicine and Health Sciences in Fargo, the patient in the report had gone to Mayo for care, and Rech had made the pathology diagnosis. But the article, “A Diagnostic Dilemma and Classification Conundrum: Atypical Histiocytic Neoplasm Presenting as a Calvarial Mass,” published in Cureus in February, didn’t mention or credit Rech or her colleagues. 

“The ability to make such a unique diagnosis is a direct result of my translational research in histiocytic neoplasms,” Rech wrote in an email to the journal in April. After she made the pathology diagnosis, a hematologist colleague saw the patient, and a group of specialists discussed the case and came to a consensus diagnosis. 

Continue reading After saying it would retract an article, Cureus changed its mind

Authors sue Sage over “discriminatory” retractions of papers cited in abortion pill case

James Studnicki

The authors of three papers about abortion Sage retracted earlier this year have sued the publisher, alleging the company pulled the articles “for pretextual and discriminatory reasons.” 

In February, Sage retracted three articles from Health Services Research and Managerial Epidemiology “because of undeclared conflicts of interest and after expert reviewers found that the studies demonstrate a lack of scientific rigor that invalidates or renders unreliable the authors’ conclusions,” according to the publisher’s statement at the time. Sage also removed the paper’s lead author from the editorial board of the journal. 

A federal judge cited two of the articles last year in his decision to suspend approval of mifepristone, a drug used in medical abortions. 

Continue reading Authors sue Sage over “discriminatory” retractions of papers cited in abortion pill case

New engineering dean has two retractions for authorship manipulation

Moncef Nehdi

A newly appointed dean at the University of Guelph in Canada has had two papers retracted for “evidence of authorship manipulation.” 

Another article by the researcher, Moncef Nehdi, formerly of McMaster University in Hamilton, Ontario, seems to match a paper that had its authorship advertised for sale, according to a post on PubPeer. 

Nehdi told Retraction Watch he stands by his group’s work in the two retracted papers, but agreed with the retractions because he thought the investigations “raised some valid concerns.” 

Nehdi began a five-year term as dean of the University of Guelph’s College of Engineering and Physical Sciences on September 1, according to an announcement this spring. The announcement stated: 

Continue reading New engineering dean has two retractions for authorship manipulation

Homeopathy for cancer paper extensively corrected after watchdog agency requested retraction

A paper that claimed to show a homeopathic intervention improved quality of life and survival for people with advanced lung cancer has received an extensive correction two years after a research integrity watchdog asked the journal to retract the article over concerns about manipulated data, Retraction Watch has learned. 

The two scientists who sounded the alarm on the paper are not satisfied with the correction, they told us. 

The article, “Homeopathic Treatment as an Add‐On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non‐Small Cell Lung Cancer: A Prospective, Randomized, Placebo‐Controlled, Double‐Blind, Three‐Arm, Multicenter Study,” appeared in The Oncologist in November 2020. Michael Frass, the lead author of the paper, is a homeopathic practitioner who was working at the Medical University of Vienna, at the time the work was published. 

Continue reading Homeopathy for cancer paper extensively corrected after watchdog agency requested retraction

Publisher adds temporary online notifications to articles “under investigation”

Some journal articles on the Taylor & Francis website now bear a pop-up notification stating the papers are “currently under investigation.” 

The publisher began adding the notices to articles such as this one in June, according to a spokesperson, as a way to inform readers about an ongoing investigation “so that they can exercise appropriate caution when considering the research presented.” 

Like the “editor’s notes” posted on Springer Nature articles under investigation, Taylor & Francis’ pop-ups only appear on the publisher’s website, not in databases where researchers might be searching for papers. 

Continue reading Publisher adds temporary online notifications to articles “under investigation”

Exclusive: Providence VA hires scientist previous employer found had harassed mentees

Kaikobad Irani

The University of Iowa found a cardiology researcher violated multiple of its policies, including harassing his former mentees when they tried to leave his lab to establish labs of their own, according to an investigation report obtained by Retraction Watch. 

The researcher, Kaikobad Irani, left the school last month with a six-figure settlement, and has a new job lined up, Retraction Watch has learned. 

Irani studies the molecular mechanisms of the function and dysfunction of blood vessels. He’s listed as an inventor on four patents, including an active one regarding a compound that could lower the risk of heart attacks and strokes. 

One of Irani’s active grants names the Providence VA Medical Center as the awardee organization. A spokesperson for the VA Providence Healthcare System confirmed Irani “is in the process of onboarding and is expected to begin working around November.” 

Continue reading Exclusive: Providence VA hires scientist previous employer found had harassed mentees

Nobel prize-winner tallies two more retractions, bringing total to 13

Gregg Semenza

A Nobel prize-winning genetics researcher has retracted two more papers, bringing his total to 13. 

Gregg Semenza, a professor of genetic medicine and director of the vascular program at Johns Hopkins’ Institute for Cell Engineering in Baltimore, shared the 2019 Nobel prize in physiology or medicine for “discoveries of how cells sense and adapt to oxygen availability.” 

Since pseudonymous sleuth Claire Francis and others began using PubPeer to point out potential duplicated or manipulated images in Semenza’s work in 2019, the researcher has retracted 12 papers. A previous retraction from 2011 for a paper co-authored with Naoki Mori – who with 31 retractions sits at No. 25 on our leaderboard – brings the total to 13. 

Continue reading Nobel prize-winner tallies two more retractions, bringing total to 13

Former Harvard cancer researcher plagiarized data, federal watchdog says

A former research fellow at Harvard Medical School faked data and used images from another scientist without attribution in a published paper and two grant applications, according to findings from the U.S. Office of Research Integrity. 

The researcher, Arunoday K. Bhan, was also a former staff scientist at City of Hope Medical Center in Duarte, Calif., and first author on “Human induced pluripotent stem cell-derived platelets loaded with lapatinib effectively target HER2+ breast cancer metastasis to the brain,” which appeared in Scientific Reports in October 2021. The article has been cited eight times. 

The paper was retracted in March. The retraction note cited an investigation by City of Hope and detailed “discrepancies in the data” that match ORI’s findings. 

Continue reading Former Harvard cancer researcher plagiarized data, federal watchdog says

Journal to retract two articles more than six months after VA said they had fake images

The Journal of Cellular Physiology, a Wiley title, will retract two articles by an arthritis researcher the U.S. Department of Veterans Affairs found to have engaged in research misconduct, Retraction Watch has learned. 

Last November, the VA published findings stating Hee-Jeong Im Sampen, formerly a research biologist at the Jesse Brown Veterans Affairs Medical Center in Chicago, faked images and inflated sample sizes in three published papers, a grant application, a presentation, and an unpublished manuscript. 

Based on the findings, the VA banned Sampen, who publishes under the name Hee-Jeong Im, from conducting research for the department and requested retractions of the three publications. 

Two of the papers, “Development of an Experimental Animal Model for Lower Back Pain by Percutaneous Injury-Induced Lumbar Facet Joint Osteoarthritis” and “Environmental Disruption of Circadian Rhythm Predisposes Mice to Osteoarthritis-Like Changes in Knee Joint,” appeared in the Journal of Cellular Physiology in 2015, and don’t currently have any sort of notice about the VA finding they contain faked images. 

Continue reading Journal to retract two articles more than six months after VA said they had fake images